Two cases of vitiligo vulgaris treated with topical Janus kinase inhibitor delgocitinib

被引：14
|
作者：
Yagi, Kumi [1 ]
Ishida, Yoshihiro [1 ]
Otsuka, Atsushi [1 ]
Kabashima, Kenji [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2021年 / 62卷 / 03期
关键词：
D O I：
10.1111/ajd.13572
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：433 / +
页数：2
相关论文
共 50 条
  • [41] Two cases of myeloid leucemia complicated with pregnancy treated with topical applications of radium
    Bower, JO
    Clark, JH
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1925, 9 : 207 - 228
  • [42] Therapeutic effects of topical Janus Kinase inhibitor VVN461 on experimental autoimmune uveitis (EAU) model in rabbits
    Li, Yong
    Lu, Yang
    Han, Qiao
    Xia, Erning
    Shen, Wang
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [43] Rapid improvement of refractory generalized granuloma annulare with the Janus kinase inhibitor baricitinib in two patients
    Kim, Dongchan
    Kang, Hee Young
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (04) : 375 - 376
  • [44] Is the treat-retreat strategy a viable option for atopic dermatitis patients undergoing Janus kinase inhibitor treatment? A report on two successful cases with upadacitinib
    Figueras-Nart, Ignasi
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (01) : E54 - E55
  • [45] Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study
    Nakagawa, Hidemi
    Nemoto, Osamu
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Kaino, Hironobu
    Nagata, Takeshi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (04) : 823 - 831
  • [46] Two cases of lupus vulgaris successfully treated with urea pura and the X rays.
    Swales, E
    LANCET, 1902, 1 : 658 - 659
  • [47] Immunomodulatory Effect of the Topical Ophthalmic Janus Kinase Inhibitor Tofacitinib (CP-690,550) in Patients with Dry Eye Disease
    Huang, Jing-Feng
    Yafawi, Rolla
    Zhang, Min
    McDowell, Michael
    Rittenhouse, Kay D.
    Sace, Frederick
    Liew, Shiao Hui
    Cooper, Scott R.
    Pickering, Eve H.
    OPHTHALMOLOGY, 2012, 119 (07)
  • [48] A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis
    Ports, W. C.
    Khan, S.
    Lan, S.
    Lamba, M.
    Bolduc, C.
    Bissonnette, R.
    Papp, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (01) : 137 - 145
  • [49] Janus kinase inhibitor adverse event profiles in dermatology patients: the experience of two academic medical centres
    Lim, Subin
    Oke, Oluwadamilola H.
    Cunningham, Kaitlynne N.
    Chau, Courtney
    Sidky, Lillian
    Cange, Bridget
    Lachance, Avery H.
    Cobos, Gabriela A.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2025,
  • [50] Two Cases of Vulval Extramammary Paget's Disease Treated with Topical Imiquimod Cream
    Swarnkar, Bhavya
    Anand, Gouri R. P.
    Ramam, M.
    Bhari, Neetu
    Agarwal, Shipra
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2024, 15 (01) : 129 - 131
12345